ISLAMABAD, Sept. 22 (Xinhua) -- Pakistan has started stage three clinical trials of a China-made vaccine for COVID-19 with the assistance of China, Executive Director of the country's National Institute of Health (NIH) Aamer Ikram said on Tuesday.
Addressing a press conference, the official said the vaccine will be administered to 8,000 to 10,000 volunteers across the country and its final results are expected to come out in about six months, following which the country will start administering it to the general public.
He said the vaccine has already been declared safe on animals and there are high expectations that it will prove safe on humans too.
Special Assistant to the country's Prime Minister on National Health Services Faisal Sultan also briefed the media on the vaccine, saying that if the clinical trial succeeded, it will not only benefit Pakistanis but the world.
Sultan said the trial of the vaccine is a vital step for Pakistan because it will help in the capacity building of the country to prepare vaccines against other viral diseases.
The vaccine has been approved for trial by the drug regulatory authority of Pakistan and it will be administered under the supervision of the NIH.
Over 300,000 people have been tested positive of COVID-19 which saw its peak during June and July in the country before witnessing a sharp decline in August.